Clinical Outcome Associated With Beta-Lactam Allergy Labels in Hospitalized Patients in Belgium
{{output}}
Background: In the United States, beta-lactam allergy labels (BLAL) are documented in 9%-16% of hospitalized patients and associated with worse clinical outcomes such as increased mortality, length of hospital stay (LOS), intensi... ...
